- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02398812
The Interprofessional Medication Assessment for Older Patients
The Interprofessional Medication Assessment for Older Patients - a Multicenter Randomized Trial in Primary Care Setting
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aging increases the risk of adverse effects and interactions caused by medication. Medication reconciliation and medication review are well-known practices to optimize medicines use. Both interventions usually require a team-based approach to be effective. Medication reconciliation is the process of obtaining and documenting a complete and accurate list of current patient medications and comparing this list with medication orders at each point of care transition to identify and rectify any discrepancies before patient harm occurs. Medication review is the process of evaluating current medication treatment to manage the risk and optimize the outcomes of medication treatment by detecting, solving, and preventing medication-related problems. The present study focuses on medication assessment including both medication reconciliation and review combined to clinical assessment of an individual patient.
According to a systematic review there is a need for research focusing on medication management in community settings and especially to assess the impact of medication assessment on clinical outcomes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Forssa, Finland, FI 30100
- Welfare district of Forssa
-
Haapajärvi, Finland, FI 85800
- Selänne Basic Health Care District
-
Juva, Finland, FI-51900
- Juva Health Care
-
Lahti, Finland, FI-15100
- City of Lahti, home care
-
Savonlinna, Finland, FI-57100
- Eastern Savo Hospital District
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Home dwelling ≥65 years-old persons registered to public home care services and who
- have had dizziness, orthostatic hypotension or have fallen or
- use at least six medicines
Exclusion Criteria:
Home care is not responsible for patient's medication, for example due to severe chronic illness (for example severe renal insufficiency or cancer with active treatment in secondary or tertiary care).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Active comparator
In addition to usual care, participants allocated to intervention group will receive medication assessment and treatment plan based on it
|
Intervention
|
|
No Intervention: Usual care
Usual care (reference group).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Functional capacity IADL (Instrumental Activities of Daily Living)
Time Frame: at 6 months from baseline
|
at 6 months from baseline
|
|
Functional capacity ADL (Activities of daily living;KATZ)
Time Frame: at 6 months from baseline
|
at 6 months from baseline
|
|
Functional capacity TUG (Timed up and go)
Time Frame: at 6 months from baseline
|
at 6 months from baseline
|
|
Functional capacity MMSE ( Mini-mental state examination)
Time Frame: at 6 months from baseline
|
at 6 months from baseline
|
|
Functional capacity GDS (Geriatric Depression Scale)-15
Time Frame: at 6 months from baseline
|
at 6 months from baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Use of health care services
Time Frame: at 6 and 12 months from baseline
|
visits to physician, hospital days and nursing care at home
|
at 6 and 12 months from baseline
|
|
Need of services delivered to home
Time Frame: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
|
Number of medicines
Time Frame: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
|
Quality of medicines
Time Frame: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
|
Cost of medicines
Time Frame: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
|
Health related quality of life assessed with EQ-5D
Time Frame: at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Pekka Mäntyselkä, MD, PROFESSOR
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ILMA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multimorbidity
-
Malin Olsen SyversenOslo University Hospital; Oslo University CollegeRecruiting
-
National Taiwan University HospitalActive, not recruiting
-
Hospital Galdakao-UsansoloHospital del Mar; Instituto de Salud Carlos III; Hospitales Universitarios Virgen... and other collaboratorsCompleted
-
Dartmouth-Hitchcock Medical CenterNational Library of Medicine (NLM)CompletedMultimorbidityUnited States
-
Central Jutland Regional HospitalCompleted
-
McMaster UniversityCompleted
-
Hospital de Clinicas de Porto AlegreNot yet recruitingMultimorbidityBrazil
-
Central Jutland Regional HospitalNot yet recruiting
-
Slagelse HospitalUniversity of CopenhagenRecruiting
-
Johns Hopkins UniversityEnrolling by invitationMultimorbidityUnited States
Clinical Trials on Medication assessment and treatment plan based on it
-
All India Institute of Medical SciencesNot yet recruitingPostpartum Depression | Perinatal Depression | Mother-Infant Bonding Disorder
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)Completed
-
BARMERGoethe University; University of Cologne; Ruhr University of Bochum; Bielefeld... and other collaboratorsCompleted
-
Foundation for Atlanta Veterans Education and Research...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Emory... and other collaboratorsActive, not recruitingType 2 DiabetesUnited States
-
NYU Langone HealthNational Institute of Mental Health (NIMH)CompletedMultimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) (MTA)Substance-related Disorders | Attention Deficit Disorder With Hyperactivity | Dyssocial Behavior
-
M.D. Anderson Cancer CenterEuropean CommissionCompletedAdvanced CancersUnited States, Spain, France, Israel
-
Fondazione Policlinico Universitario Agostino Gemelli...Fundacion Clinic per a la Recerca Biomédica; Newcastle University; University...RecruitingRheumatoid ArthritisItaly, Spain, United Kingdom
-
Diagram B.V.AbbottActive, not recruitingIschemia | Coronary Artery Disease | Multivessel Coronary Artery Disease | Vulnerable PlaqueSpain, Taiwan, Netherlands, Denmark, Sweden, Germany, New Zealand, France, Poland, Japan, Italy, India, Canada, Australia, Estonia, Malaysia, Romania, Slovakia
-
Jianjun Yang,MDRecruitingGastrointestinal Tumors,3D Organoids,Drug SensitivityChina
-
Baylor College of MedicineCompletedSeizures | Development Delay | Anesthetic NeurotoxicityUnited States